Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 3/20 | 0.43 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.43 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.43 |
| ▸ | MAOA | P21397 | 1/20 | 0.43 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.43 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.43 |
| ▸ | HTR2B | P41595 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
| ▸ | GAA | P10253 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.39 |
| ▸ | RAPGEF4 | Q8WZA2 | 5/20 | 0.37 |
| ▸ | CD44 | P16070 | 1/20 | 0.36 |
| ▸ | PDE3B | Q13370 | 1/20 | 0.32 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.32 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.30 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.30 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.30 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.30 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31497683 | 1.00 | CYP3A4 (0.43) | CYP3A4CHRM1ALOX15MAOATBXA2R | |
| SCHEMBL9419974 | 0.82 | CYP3A4 (0.43) | CYP3A4CHRM1ALOX15MAOATBXA2R | |
| SCHEMBL31465325 | 0.82 | CYP3A4 (0.43) | CYP3A4CHRM1ALOX15MAOATBXA2R | |
| SCHEMBL1006177 | 0.82 | CYP3A4 (0.43) | CYP3A4CHRM1ALOX15MAOATBXA2R | |
| SCHEMBL28492412 | 0.80 | CYP3A4 (0.42) | CYP3A4CHRM1ALOX15MAOATBXA2R | |
| Water SCHEMBL28512050 | 0.80 | CYP3A4 (0.42) | CYP3A4CHRM1ALOX15MAOATBXA2R | |
| SCHEMBL906696 | 0.79 | CYP3A4 (0.46) | CYP3A4CHRM1ALOX15MAOATBXA2R | |
| SCHEMBL17473830 | 0.79 | CD44 (0.38) | CYP3A4CHRM1ALOX15MAOATBXA2R | |
| SCHEMBL25978067 | 0.79 | CYP3A4 (0.50) | CYP3A4CHRM1ALOX15MAOATBXA2R | |
| SCHEMBL1003476 | 0.78 | CYP3A4 (0.50) | CYP3A4CHRM1ALOX15MAOATBXA2R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6831111-B1 | New or recycled Polystyrene and copolymers processed to become macroreticular, structure designed to absorb organic solvents and oil molecularly; crosslinked with 1,4-dichloromethyl-2,5-dichloromethyl-2,5- dimethylbenzene | INNOVAL MANAGEMENT LIMITED (AN) | 2004-12-14 | — | — | US | claimed |
| EP-1025135-B1 | METHOD OF PREPARATION OF PRODUCTS WHICH ABSORB WATER INTRAMOLECULARLY | INNOVAL MAN LTD (AN) | 2004-09-29 | — | — | EP | claimed |
| EP-0902795-B1 | METHOD AND PRODUCTS TO ABSORB OIL AND ORGANIC SOLVENTS FROM WATER AND FROM SEA | INNOVAL MAN LTD (AN) | 2002-12-04 | — | — | EP | claimed |
| US-6476152-B1 | Method of preparation of products which absorb water intermolecularly | INNOVAL MANAGEMENT, LTD. (NL) | 2002-11-05 | — | — | US | claimed |
| EP-1025135-A1 | METHOD OF PREPARATION OF PRODUCTS WHICH ABSORB WATER INTERMOLECULARLY | Innoval Management Limited (AN) | 2000-08-09 | — | — | EP | claimed |
| WO-1999021897-A1 | METHOD OF PREPARATION OF PRODUCTS WHICH ABSORB WATER INTERMOLECULARLY | INNOVAL MANAGEMENT LIMITED (AN) | 1999-05-06 | — | — | WO | claimed |
| JP-2229136-A | — | — | None | — | — | JP | disclosed |
| US-20240216355-A1 | PHARMACEUTICAL COMPOSITIONS FOR USE IN THE PREVENTION AND TREATMENT OF A DISEASE OR DISORDER CAUSED BY OR ASSOCIATED WITH ONE OR MORE PREMATURE TERMINATION CODONS | MONTE ROSA THERAPEUTICS AG (CH) | 2024-07-04 | — | — | US | disclosed |
| US-20240216355-A1 | PHARMACEUTICAL COMPOSITIONS FOR USE IN THE PREVENTION AND TREATMENT OF A DISEASE OR DISORDER CAUSED BY OR ASSOCIATED WITH ONE OR MORE PREMATURE TERMINATION CODONS | MONTE ROSA THERAPEUTICS AG (CH) | 2024-07-04 | — | — | US | disclosed |
| US-20230132149-A1 | ULTRA NARROW BANDGAP NON-FULLERENE-ACCEPTOR BASED ORGANIC ELECTRONICS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2023-04-27 | — | — | US | disclosed |
| EP-2137228-B1 | POLYESTER COMPOSITIONS HAVING IMPROVED HEAT RESISTANCE | SABIC INNOVATIVE PLASTICS IP (NL) | 2011-01-12 | — | — | EP | disclosed |
| US-20080242783-A1 | POLYESTER COMPOSITIONS HAVING IMPROVED HEAT RESISTANCE | CITIBANK, N.A., AS COLLATERAL AGENT | 2008-10-02 | — | — | US | disclosed |
| US-20080242784-A1 | POLYESTER COMPOSITIONS HAVING IMPROVED HEAT RESISTANCE | CITIBANK, N.A., AS COLLATERAL AGENT | 2008-10-02 | — | — | US | disclosed |
| US-4880901-A | DICHLOROAROMATICS WITH SODIUM SULFIDE AND ONE TRIHALOAROMATIC, INJECTION MOLDING | PHILLIPS PETROLEUM COMPANY (US) | 1989-11-14 | — | — | US | disclosed |
| EP-0318836-A2 | Poly(arylene sulfide) process compositions and articles of manufacture | PHILLIPS PETROLEUM COMPANY (US) | 1989-06-07 | — | — | EP | disclosed |
| EP-0100551-B1 | ARYLENE SULFIDE TERPOLYMERS AND PROCESSES FOR MAKING THEM | PHILLIPS PETROLEUM COMPANY (US) | 1987-07-15 | — | — | EP | disclosed |
| EP-0176292-A2 | Aromatic polymers | NATIONAL RESEARCH DEVELOPMENT CORPORATION (GB) | 1986-04-02 | — | — | EP | disclosed |
| EP-0100551-A2 | Arylene sulfide terpolymers and processes for making them | PHILLIPS PETROLEUM COMPANY (US) | 1984-02-15 | — | — | EP | disclosed |
| US-4059610-A | Process for preparing isocyanic acid derivatives | KAO SOAP CO., LTD. (JA) | 1977-11-22 | — | — | US | disclosed |
| US-4056547-A | FROM AN ALKALI METAL OR AMMONIUM CYANATE AND A BENZYL CHLORIDE, CATALYST | KAO SOAP CO., LTD. (JA) | 1977-11-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240216355-A1 | PHARMACEUTICAL COMPOSITIONS FOR USE IN THE PREVENTION AND TREATMENT OF A DISEASE OR DISORDER CAUSED BY OR ASSOCIATED WITH ONE OR MORE PREMATURE TERMINATION CODONS | UPF1, NSUN2, RTF2 | CYP3A4 3128/4885CHRM1 901/4885ALOX15 2992/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.